Profiles of gene expression & diagnosis/prognosis of cancer

Slides:



Advertisements
Similar presentations
Serial Analysis of Gene Expression Velculescu, V., Zhang, L., Vogelstein, B. Kinzler, K. (1995) Science.
Advertisements

Ovarian Cancer: How Basic Research Can Lead to New Opportunities for Early Detection and Treatment.
Yan Guo Assistant Professor Department of Cancer Biology Vanderbilt University USA.
 2013 Genentech USA, Inc. All rights reserved. Disclosure/Disclaimer The Molecular Biomarkers in Cancer (MBiC) slide presentation is not an independent.
MiRNA-drug resistance mechanisms Summary Hypothesis: The interplay between miRNAs, signaling pathways and epigenetic and genetic alterations are responsible.
MiRNA Platform Overview The Agilent miRNA Microarray System A New Microarray-based Tool for Profiling Human miRNAs.
Microarrays Dr Peter Smooker,
Introduction of Cancer Molecular Epidemiology Zuo-Feng Zhang, MD, PhD University of California Los Angeles.
 MicroRNAs (miRNAs) are a class of small RNA molecules, about ~21 nucleotide (nt) long.  MicroRNA are small non coding RNAs (ncRNAs) that regulate.
KRAS testing in colorectal cancer: an overview. 2 What is KRAS? KRAS is a gene that encodes one of the proteins in the epidermal growth factor receptor.
Presented by Karen Xu. Introduction Cancer is commonly referred to as the “disease of the genes” Cancer may be favored by genetic predisposition, but.
Paola CASTAGNOLI Maria FOTI Microarrays. Applicazioni nella genomica funzionale e nel genotyping DIPARTIMENTO DI BIOTECNOLOGIE E BIOSCIENZE.
Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3.
Chapter 7 Essential Concepts in Molecular Pathology Companion site for Molecular Pathology Author: William B. Coleman and Gregory J. Tsongalis.
DNA MICROARRAYS WHAT ARE THEY? BEFORE WE ANSWER THAT FIRST TAKE 1 MIN TO WRITE DOWN WHAT YOU KNOW ABOUT GENE EXPRESSION THEN SHARE YOUR THOUGHTS IN GROUPS.
Finish up array applications Move on to proteomics Protein microarrays.
Computational biology of cancer cell pathways Modelling of cancer cell function and response to therapy.
吳 華 席 Hua-Hsi Wu, MD OB/GYN, VGH-TPE Aug 12, 2008
Marco Magistri , Journal Club. A non-coding RNA (ncRNA) is any RNA molecule that is not translated into a protein “Structural genes encode proteins.
Apostolos Zaravinos and Constantinos C Deltas Molecular Medicine Research Center and Laboratory of Molecular and Medical Genetics, Department of Biological.
SP Cancer Metastasis Summary Hypothesis: We hypothesize that miRNAs regulate breast cancer cell invasiveness and metastasis by synergistically targeting.
Causes and consequences of microRNA dysregulation in cancer
MCB 317 Genetics and Genomics Topic 11 Genomics. Readings Genomics: Hartwell Chapter 10 of full textbook; chapter 6 of the abbreviated textbook.
Dr Godfrey Grech University of Malta
ANALYSIS OF GENE EXPRESSION DATA. Gene expression data is a high-throughput data type (like DNA and protein sequences) that requires bioinformatic pattern.
CBioPortal Web resource for exploring, visualizing, and analyzing multidimentional cancer genomics data.
Case Study: Characterizing Diseased States from Expression/Regulation Data Tuck et al., BMC Bioinformatics, 2006.
PLANT BIOTECHNOLOGY & GENETIC ENGINEERING (3 CREDIT HOURS) LECTURE 13 ANALYSIS OF THE TRANSCRIPTOME.
Annals of Oncology 23: 298–304, 2012 종양혈액내과 R4 김태영 / prof. 김시영.
Different microarray applications Rita Holdhus Introduction to microarrays September 2010 microarray.no Aim of lecture: To get some basic knowledge about.
Multi-scale network biology model & the model library 多尺度网络生物学模型 -- 兼论模型库的建立与应用 Jianghui Xiong 熊江辉
Evolution-informed Modeling discover biomarkers for precision oncology Li Liu, M.D. August 22, 2016.
San Antonio Breast Cancer Symposium – December 6-10, 2016
miRNA-targets cross-talks: key players in glioblastoma multiforme
OMICS Journals are welcoming Submissions
Sungkyunkwan University, School of Medicine.
Estrogen receptor-α directly regulates the hypoxia inducible factor 1 pathway associated with antiestrogen response in breast cancer PNAS (49)
GENETIC BIOMARKERS.
1. SELECTION OF THE KEY GENE SET 2. BIOLOGICAL NETWORK SELECTION
MicroRNA-34a: a key regulator in the hallmarks of renal cell carcinoma
Polymerase Chain Reaction (PCR) and Its Applications
An Artificial Intelligence Approach to Precision Oncology
FINAL PROJECT- Key dates
Gene expression.
Predictive Biomarkers for Lung Cancer
Biomedical Therapies Foundation Standard 1: Academic Foundation
Techniques for measuring minimal residual disease in leukemia
Microarray Technology and Applications
Assistant Prof. Dr. Nibras Saleam Al-Ammar PhD in Clinical Immunology
Dept of Biomedical Informatics University of Pittsburgh
High-level TNFSF13 predict a good response to post-operative chemotherapy in patients with basal-like breast cancer: A systematic review 林惠鈺1,2 歸家豪1,3.
Polymerase Chain Reaction (PCR)
Cell Signaling.
Characterization of microRNA transcriptome in tumor, adjacent, and normal tissues of lung squamous cell carcinoma  Jun Wang, MD, PhD, Zhi Li, MD, PhD,
objectives Methods Results conclusion
Loyola Marymount University
Transcriptional Signature of Histone Deacetylases in Breast cancer
Review Warm-Up What is the Central Dogma?
Jean-Charles Nault, Peter R. Galle, Jens U. Marquardt 
Diagnostics and Prognostics
Gene Expression Analysis
MicroRNAs in cancer: biomarkers, functions and therapy
Products > CLBPEC Transfection Reagent (Neuroblastoma Cells)
Loyola Marymount University
Loyola Marymount University
RealTime-PCR.
Loyola Marymount University
Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours By: Anh Pham.
Loyola Marymount University
MicroRNAs in cancer: biomarkers, functions and therapy
Presentation transcript:

Profiles of gene expression & diagnosis/prognosis of cancer Lucia Gómez Pardo. Advanced Genetics. Genomics December 2016

Central Dogma of Biology Transcriptome Gene expression Flow of genetic information

Gene expression profiles Gene expression profiling is the determination of the pattern of genes expressed, at the level of transcription, under specific circumstances or in a specific cell to give a global picture of cellular function. Identify the molecular basis of phenotypic differences

Clustering of expression profiles defines in breast cancer cell line subtypes. Kao, J. et al. Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery. PLoS ONE 4, e6146 (2009).

Gene expression profiles in cancer Uncontrolled cell growth and proliferation. The genes regulating cell growth and differentiation must be altered; these mutations are then maintained through subsequent cell divisions. Gene expression profiling has been used to more accurately classify tumours. Impact on predicting the patient`s clinical outcome.

Gene expression profiles in cancer Workflow individualized therapies in cancer Tumor harvest

Aplications Develop new biological concepts Disease classification Improve diagnostic and prognostic accuracy Identify new molecular targets for drugs Help to choose an adequate therapy for every patient

Techniques DNA microarray Real time PCR (qPCR) Serial Analysis of Gene Expression SAGE RNA seq MicroRNA

Most common method of studying gene expression. Since the advent of genome‐wide transcriptome profiling by DNA microarray, gene signatures of poor prognosis and chemoresistance in cancer tissue have been studied to improved prognostic and diagnostic tools in the clinic. The Gene Expression Omnibus (GEO) database.

RT-qPCR Steady-state levels of mRNA are quantitated by reverse transcription of the RNA to cDNA followed by quantitative PCR (qPCR) The amount of each specific target is determined by measuring the increase in fluorescence signal from DNA-binding dyes or probes during successive rounds of enzyme-mediated amplification.

High-throughput gene expression analysis aims to quantify messenger RNA (mRNA) populations in a given tissue of Breast cancer tumor. Marchionni L, Wilson RF, Wolff AC, Marinopoulos S, Parmigiani G, Bass EB, et al. Systematic Review: Gene Expression Profiling Assays in Early-Stage Breast Cancer. Ann Intern Med. 2008;148:358-369. 

Serial Analysis of Gene Expression (SAGE) Serial analysis of gene expression is an approach that allows rapid and detailed analysis of gene expression patterns. SAGE provides quantitative and comprehensive expression profiling in a given cell population.

Serial Analysis of Gene Expression (SAGE) Data output is a specific gene fragment sequence and a count for the frequency with which that fragment appeared in a sample.

RNA-seq RNA-Seq is a recently developed approach to transcriptome profiling that uses next-generation sequencing (NGS) to reveal the presence and quantity of RNA in a biological sample at a given moment in time. While gene expression microarrays are effective for identifying the expression of known genes and transcripts, they cannot detect previously unknow transcripts. In contrast, RNA-Seq offers a gene expression profiling solution, allowing researchers to detect both known and novel in a single assay. Wang, Z. et al., 2009

MicroRNA expression profiling MiRNAs are promising in the diagnosis of cancer, drug target identification and clinical treatment in the future. MicroRNA expression profiling miRNAs are small non- coding regions of 20-22 nt, they play an important role in all biological pathways by safeguarding key biological processes: Cell proliferation Differentiation Apoptosis. Deregulation of the miRNAs has severe consequences in the expression patterns of a lot of mRNAs and this deregulation is involved in the development of many disease. Chen et al., 2012

Find new, more precise molecular markers for leukemia classification. Although the methods by which leukemia is classified have been improved for effective therapies, leukemia patients occasionally exhibit diverse, sometimes unpredictable, responses to treatment. Objective: Find new, more precise molecular markers for leukemia classification. Experiment: Analyzed the gene expression profiles from 65 diagnostic bone marrow specimens of adult patients with: AML ALL CML CLL High-throughput DNA microarrays harboring approximately 8300 unique human genes or expression sequence tags.

A B

Conclusions and Future Perspectives Complex trait analysis describes an area of biology that is extremely crucial to our understanding of most prevalent human diseases, such as cancer. How is modern biomedical science expected to identify genes modulating complex disease and produce the development of new treatments? Tools for the organization of genomic-level data into networks. Analysis of multiple experimental conditions. Quantitative measurements of gene expression are important for a wide range of research and diagnostic applications. Molecular profiles of tumors hold great promise as biomarkers of clinical outcomes. It is likely that gene expression will increase the basis for diagnostic assays that identify the onset of a disease and monitor its progression and prognosis. Enviromental factor Phenotypic expression of didease Multiple genes

References Marchionni L, Wilson RF, Wolff AC, Marinopoulos S, Parmigiani G, Bass EB, et al. Systematic Review: Gene Expression Profiling Assays in Early-Stage Breast Cancer. Ann Intern Med. 2008;148:358-369. doi: 10.7326/0003-4819-148-5-200803040-00208. Bio-Rad. (2015). What is Gene Expression Analysis? Online at: http://www.bio-rad.com/eses/applications-technologies/what-gene-expression-analysis. Lun, J. et al. (2005). MicroRNA expression profiles classify human cancers. Nature, 435. Gabriele, L., Moretti, F., Pierotti, M. A., Marincola, F. M., Foà, R., & Belardelli, F. M. (2006). The use of microarray technologies in clinical oncology. Journal of Translational Medicine, 4, 8. doi:10.1186/1479-5876-4-8 . Ross M, Mahfouz R, Onciu M, (2004). Gene expression profiling of pediatric acute myelogenous leukemia. 10.1182/blood-2004-03-1154. Ju Song, Hyeoung-joon kim et al. (2006). Identification of gene expression signatures for molecular classification in human leukemia cells. International Journal of Oncology 29: 57-64. Su AI, Welsh JB, Sapinoso LM, et al: Molecular classification of human carcinomas by use of gene expression signatures. Cancer Res 61: 7388-7393, 2001. Ramaswamy S, Tamayo P, Rifkin R, et al: Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci USA 98: 15149-15154, 2001.